Revenue | ₹33.69Cr |
Net Profits | ₹-3.93Cr |
Net Profit Margins | -11.67% |
Oxygenta Pharmaceutical Ltd’s revenue jumped 266.99% since last year same period to ₹33.69Cr in the Q3 2024-2025. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated 128.41% jump in its revenue since last 3-months.
Oxygenta Pharmaceutical Ltd’s net profit fell -3.97% since last year same period to ₹-3.93Cr in the Q3 2024-2025. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated -37.89% fall in its net profits since last 3-months.
Oxygenta Pharmaceutical Ltd’s net profit margin jumped 71.67% since last year same period to -11.67% in the Q3 2024-2025. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated 39.63% jump in its net profit margins since last 3-months.
The revenue for Oxygenta Pharmaceutical Ltd in the Q3 results 2024 was ₹33.69Cr.
The net profit for Oxygenta Pharmaceutical Ltd in the Q3 results 2024 was ₹-3.93Cr.
The net profit margin for Oxygenta Pharmaceutical Ltd in the Q3 results 2024 was -11.67%.
The revenue for Oxygenta Pharmaceutical Ltd in the Q3 results 2023 was ₹9.18Cr.
The net profit for Oxygenta Pharmaceutical Ltd in the Q3 results 2023 was ₹-3.78Cr.
The net profit margin for Oxygenta Pharmaceutical Ltd in the Q3 results 2023 was -41.18%.